| CAS NO: | 1448221-05-3 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 生物活性 | Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocksVEGF-Aandangiopoietin-2 (Ang-2)from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects[1]. | ||||||||
| 体内研究 (In Vivo) | Vanucizumab (20mg /kg;i.p。每周1次;6周) 显示肿瘤生长抑制和诱导肿瘤停滞[2]。
| ||||||||
| CAS 号 | 1448221-05-3 | ||||||||
| 中文名称 | 伐努赛珠单抗 | ||||||||
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com